{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:08:47Z","timestamp":1762999727041,"version":"3.44.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.ad.2021.12.015","type":"journal-article","created":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T19:59:04Z","timestamp":1643572744000},"page":"498-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tiazidas: lo que el dermat\u00f3logo deber\u00eda saber"],"prefix":"10.1016","volume":"113","author":[{"given":"J.M.","family":"Llamas-Molina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.J.","family":"Navarro-Trivi\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ruiz-Villaverde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ad.2021.12.015_bib0255","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra0907219","article-title":"Use of diuretics in patients with hypertension","volume":"361","author":"Ernst","year":"2009","journal-title":"N Engl J Med."},{"key":"10.1016\/j.ad.2021.12.015_bib0260","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/jch.13386","article-title":"Hydrochlorothiazide vs chlorthalidone, indapamide, and potassium-sparing\/hydrochlorothiazide diuretics for reducing left ventricular hypertrophy: A systematic review and meta-analysis","volume":"20","author":"Roush","year":"2018","journal-title":"J Clin Hypertens (Greenwich)."},{"year":"2021","series-title":"Thiazide Diuretics","author":"Akbari","key":"10.1016\/j.ad.2021.12.015_bib0265"},{"key":"10.1016\/j.ad.2021.12.015_bib0270","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/5584_2018_182","article-title":"The Art and Science of Using Diuretics in the Treatment of Heart Failure in Diverse Clinical Settings","volume":"1067","author":"Islam","year":"2018","journal-title":"Adv Exp Med Biol."},{"key":"10.1016\/j.ad.2021.12.015_bib0275","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/BF00562454","article-title":"Pharmacokinetic studies with chlorthalidone (Hygroton) in man","volume":"12","author":"Riess","year":"1977","journal-title":"Eur J Clin Pharmacol."},{"key":"10.1016\/j.ad.2021.12.015_bib0280","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/14656566.2014.879118","article-title":"Diuretics in the treatment of hypertension Part 1: thiazide and thiazide-like diuretics","volume":"15","author":"Tamargo","year":"2014","journal-title":"Expert Opin Pharmacother."},{"key":"10.1016\/j.ad.2021.12.015_bib0285","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.2174\/1389200219666180702104559","article-title":"Thiazide Therapy in Chronic Kidney Disease: Renal and Extra Renal Targets","volume":"19","author":"Pourafshar","year":"2018","journal-title":"Curr Drug Metab."},{"issue":"1\u20132","key":"10.1016\/j.ad.2021.12.015_bib0290","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0781.1997.tb00103.x","article-title":"Clinical drug photosensitivity. A retrospective analysis of reports to the Norwegian Adverse Drug Reactions Committee from the years 1970-1994","volume":"13","author":"Selvaag","year":"1997","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"10.1016\/j.ad.2021.12.015_bib0295","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40264-019-00806-5","article-title":"Drug-Induced Photosensitivity-An Update: Culprit Drugs Prevention and Management","volume":"42","author":"Blakely","year":"2019","journal-title":"Drug Saf."},{"key":"10.1016\/j.ad.2021.12.015_bib0300","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/15569527.2010.491103","article-title":"Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by telmisartan-hydrochlorothiazide","volume":"29","author":"Ferreira","year":"2010","journal-title":"Cutan Ocul Toxicol."},{"key":"10.1016\/j.ad.2021.12.015_bib0305","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/php.12048","article-title":"Hydrochlorothiazide enhances UVA-induced DNA damage","volume":"89","author":"Kunisada","year":"2013","journal-title":"Photochem Photobiol."},{"key":"10.1016\/j.ad.2021.12.015_bib0310","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/1523-1747.ep12456307","article-title":"Lipid peroxidative potency of photosensitized thiazide diuretics","volume":"87","author":"Matsuo","year":"1986","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0315","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ad.2013.01.010","article-title":"Photosensitivity due to thiazides","volume":"105","author":"G\u00f3mez-Bernal","year":"2014","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2021.12.015_bib0320","first-page":"00882","article-title":"Increased susceptibility to sunburn with hydrochlorothiazide is influenced by race\/ethnicity, sex, and treatment duration: Results from the National Health and Nutrition Examination Survey, 2009-2018","volume":"S0190\u20139622","author":"Tsai","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0325","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1600-0781.1996.tb00209.x","article-title":"Photoaugmentation effects demonstrated in vitro","volume":"12","author":"Selvaag","year":"1996","journal-title":"Photodermatol Photoimmunol Photomed."},{"key":"10.1016\/j.ad.2021.12.015_bib0330","first-page":"572","article-title":"Allergic vasculitis induced by hydrochlorothiazide: confirmation by mast cell degranulation test","volume":"25","author":"Grunwald","year":"1989","journal-title":"Isr J Med Sci."},{"key":"10.1016\/j.ad.2021.12.015_bib0335","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/archderm.1985.01660040106021","article-title":"Thiazide diuretic therapy and chronic photosensitivity","volume":"121","author":"Robinson","year":"1985","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0340","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ad.2019.06.008","article-title":"Tiazidas y c\u00e1ncer cut\u00e1neo no melanoma","volume":"112","author":"Rodr\u00edguez-Jim\u00e9nez","year":"2021","journal-title":"Actas Dermosifiliogr."},{"key":"10.1016\/j.ad.2021.12.015_bib0345","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jaad.2017.11.042","article-title":"Hydrochlorothiazide use and risk of non-melanoma skin cancer: A nationwide case-control study from Denmark","volume":"78","author":"Pedersen","year":"2018","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0350","doi-asserted-by":"crossref","first-page":"247","DOI":"10.14740\/jocmr3744","article-title":"Association Between the Use of Thiazide Diuretics and the Risk of Skin Cancers: A Meta-Analysis of Observational Studies","volume":"11","author":"Shin","year":"2019","journal-title":"J Clin Med Res."},{"key":"10.1016\/j.ad.2021.12.015_bib0355","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s11886-019-1183-z","article-title":"Do Thiazide Diuretics Increase the Risk of Skin Cancer?. A Critical Review of the Scientific Evidence and Updated Meta-Analysis","volume":"21","author":"Bendinelli","year":"2019","journal-title":"Curr Cardiol Rep."},{"key":"10.1016\/j.ad.2021.12.015_bib0360","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.1503\/cmaj.201971","article-title":"Association between antihypertensive medications and risk of skin cancer in people older than 65 years: a population-based study","volume":"193","author":"Drucker","year":"2021","journal-title":"CMAJ."},{"key":"10.1016\/j.ad.2021.12.015_bib0365","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1001\/jamainternmed.2018.1652","article-title":"Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma","volume":"178","author":"Potteg\u00e5rd","year":"2018","journal-title":"JAMA Intern Med."},{"key":"10.1016\/j.ad.2021.12.015_bib0370","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40264-020-01015-1","article-title":"Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer","volume":"44","author":"Rouette","year":"2021","journal-title":"Drug Saf."},{"key":"10.1016\/j.ad.2021.12.015_bib0375","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/bjd.19880","article-title":"Risk of skin cancer in new users of thiazides and thiazide-like diuretics: a cohort study using an active comparator group","volume":"185","author":"Schneider","year":"2021","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0380","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jaad.2018.06.014","article-title":"Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study","volume":"80","author":"Pedersen","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0385","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/cncr.27740","article-title":"Hydrochlorothiazide and cutaneous T cell lymphoma: prospective analysis and case series","volume":"119","author":"Jahan-Tigh","year":"2013","journal-title":"Cancer."},{"key":"10.1016\/j.ad.2021.12.015_bib0390","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/jdv.16833","article-title":"Cutaneous T-cell lymphoma after chronic exposure to hydrochlorothiazide: pharmacovigilance analysis from the RADAR (Research on Adverse Drug events And Reports) Program","volume":"35","author":"Pease","year":"2021","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.ad.2021.12.015_bib0395","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40266-015-0246-0","article-title":"Chronic pruritus in the elderly: pathophysiology, diagnosis and management","volume":"32","author":"Valdes-Rodriguez","year":"2015","journal-title":"Drugs Aging."},{"key":"10.1016\/j.ad.2021.12.015_bib0400","first-page":"84","article-title":"Pruritus Associated with Commonly Prescribed Medications in a Tertiary Care Center","volume":"6","author":"Huang","year":"2019","journal-title":"Medicines (Basel)."},{"key":"10.1016\/j.ad.2021.12.015_bib0405","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jamadermatol.2013.511","article-title":"Chronic eczematous eruptions in the aging: further support for an association with exposure to calcium channel blockers","volume":"149","author":"Summers","year":"2013","journal-title":"JAMA Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0410","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/ACI.0000000000000181","article-title":"Cutaneous adverse drug reactions in the elderly","volume":"15","author":"Heng","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol."},{"key":"10.1016\/j.ad.2021.12.015_bib0415","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/BOR.0000000000000522","article-title":"Drug-induced lupus erythematosus: an update on drugs and mechanisms","volume":"30","author":"He","year":"2018","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0420","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/17512433.2020.1698290","article-title":"Cutaneous lupus erythematosus induced by drugs - novel insights","volume":"13","author":"Borucki","year":"2020","journal-title":"Expert Rev Clin Pharmacol."},{"key":"10.1016\/j.ad.2021.12.015_bib0425","doi-asserted-by":"crossref","first-page":"49","DOI":"10.7326\/0003-4819-103-1-49","article-title":"Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy","volume":"103","author":"Reed","year":"1985","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.ad.2021.12.015_bib0430","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0190-9622(88)70005-5","article-title":"Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene","volume":"18","author":"Darken","year":"1988","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0435","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3109\/15563659509010639","article-title":"Thiazide diuretics induce cutaneous lupus-like adverse reaction","volume":"33","author":"Brown","year":"1995","journal-title":"J Toxicol Clin Toxicol."},{"key":"10.1016\/j.ad.2021.12.015_bib0440","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12659\/AJCR.911380","article-title":"When Chest Pain Reveals More: A Case of Hydrochlorothiazide-Induced Systemic Lupus Erythematosus","volume":"20","author":"Sosenko","year":"2019","journal-title":"Am J Case Rep."},{"key":"10.1016\/j.ad.2021.12.015_bib0445","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.semerg.2012.02.002","article-title":"Penfigoide ampolloso inducido por hidroclorotiazida [Hydrochlorothiazide induced bullous pemphigoid]","volume":"39","author":"Garc\u00eda Sanchez","year":"2013","journal-title":"Semergen."},{"key":"10.1016\/j.ad.2021.12.015_bib0450","first-page":"360","article-title":"Bullous pemphigoid induced by hydrochlorothiazide therapy","volume":"13","author":"Warner","year":"2014","journal-title":"J Drugs Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0455","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.clindermatol.2020.06.010","article-title":"Fixed drug eruptions, bullous drug eruptions, and lichenoid drug eruptions","volume":"38","author":"Cheraghlou","year":"2020","journal-title":"Clin Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0460","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1046\/j.1365-2230.2002.01108.x","article-title":"Thiazide-induced lichenoid photosensitivity","volume":"27","author":"Johnston","year":"2002","journal-title":"Clin Exp Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0465","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/jid.1959.126","article-title":"Skin manifestations of photosensitivity due to chlorothiazide and hydrochlorothiazide","volume":"33","author":"Harber","year":"1959","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.ad.2021.12.015_bib0470","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/0897190016630879","article-title":"Hydrochlorothiazide Induced Lichen Planus in the Emergency Department","volume":"30","author":"Sin","year":"2017","journal-title":"J Pharm Pract."},{"key":"10.1016\/j.ad.2021.12.015_bib0475","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1398-9995.2006.01052.x","article-title":"Lichenoid drug eruption due to an antihypertonic drug containing irbesartan and hydrochlorothiazide","volume":"61","author":"Pfab","year":"2006","journal-title":"Allergy."},{"key":"10.1016\/j.ad.2021.12.015_bib0480","first-page":"194","article-title":"Leukocytoclastic vasculitis due to hydrochlorthiazide","volume":"103","author":"Shah","year":"2007","journal-title":"J S C Med Assoc."},{"key":"10.1016\/j.ad.2021.12.015_bib0485","article-title":"Dermacase. Can you identify this condition? Drug-induced leukocytoclastic vasculitis","volume":"59","author":"Binamer","year":"2013","journal-title":"Can Fam Physician."},{"key":"10.1016\/j.ad.2021.12.015_bib0490","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/000155501750376348","article-title":"Hydrochlorothiazide-induced acute generalized exanthematous pustulosis","volume":"81","author":"P\u00e9tavy-Catala","year":"2001","journal-title":"Acta Derm Venereol."},{"key":"10.1016\/j.ad.2021.12.015_bib0495","doi-asserted-by":"crossref","first-page":"e223528","DOI":"10.1136\/bcr-2017-223528","article-title":"Hydrochlorothizide-induced acute generalised exanthematous pustulosis presenting with bilateral periorbital impetigo","volume":"12","author":"Reap","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ad.2021.12.015_bib0500","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.amjopharm.2006.12.002","article-title":"Hydrochlorothiazide-induced angioedema in a patient allergic to sulfonamide antibiotics: evidence from a case report and a review of the literature","volume":"4","author":"Ruscin","year":"2006","journal-title":"Am J Geriatr Pharmacother."}],"container-title":["Actas Dermo-Sifiliogr\u00e1ficas"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731022000230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001731022000230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T01:13:11Z","timestamp":1757553191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001731022000230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S0001731022000230"],"URL":"https:\/\/doi.org\/10.1016\/j.ad.2021.12.015","relation":{},"ISSN":["0001-7310"],"issn-type":[{"type":"print","value":"0001-7310"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tiazidas: lo que el dermat\u00f3logo deber\u00eda saber","name":"articletitle","label":"Article Title"},{"value":"Actas Dermo-Sifiliogr\u00e1ficas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ad.2021.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AEDV. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}